CHOSA Oncology appoints US commercialization Bill Cronin with a broad network in the oncology market, to accelerate launch of Platin-DRP... These results further support CHOSA''s US commercialization strategy for Platin-DRP®.
More than 48,000 DoD staff — more than 6 percent of its workforce — were approved to leave under DRP as of June 2025, the watchdog said ... Another lost 31 people to DRP, or almost 6 percent of its workforce.
) CHOSA Oncology establishes US presence in Boston to support commercialization of Platin-DRP... As previously announced, CHOSA is also exploring the predictive potential of Platin-DRP in those treated with carboplatin in lung cancer.
CHOSA Oncology establishes US presence in Boston to support commercialization of Platin-DRP... As previously announced, CHOSA is also exploring the predictive potential of Platin-DRP in those treated with carboplatin in lung cancer.